License AgreementLicense Agreement • June 13th, 2016 • Eleven Biotherapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJune 13th, 2016 Company Industry JurisdictionWHEREAS, Eleven has discovered proprietary IL-6 antagonist monoclonal antibodies, including the compound known as EBI-031 (as defined below), and possesses proprietary intellectual property rights relating thereto; and